HUHS015 - CAS 1453097-13-6
Catalog number: 1453097-13-6
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
Others
Description:
HUHS015 is a potent PCA-1/ALKBH3 inhibitor both in vitro and in vivo. The bioavailability (BA) of HUHS015 was 7.2% in rats after oral administration. As expected, continuously administering HUHS015 significantly suppressed the growth of DU145 cells, which are human hormone-independent prostate cancer cells, in a mouse xenograft model without untoward effects.
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.98
Appearance:
white solid powder
Synonyms:
HUHS015; HUHS 015; HUHS-015
MSDS:
Inquire
1.Improving the bioavailability and anticancer effect of the PCA-1/ALKBH3 inhibitor HUHS015 using sodium salt.
Mabuchi M1, Shimizu T1, Ueda M1, Sasakawa Y2, Nakao S1, Ueda Y3, Kawamura A4, Tsujikawa K3, Tanaka A5. In Vivo. 2015 Jan-Feb;29(1):39-43.
Prostate cancer antigen (PCA)-1/AlkB homologue 3 (ALKBH3) has been identified as a clinically significant factor and siRNA of PCA-1 inhibits DU145 proliferation both in vitro and in vivo. HUHS015 ( 1: ), a previous reported PCA-1 small-molecule inhibitor, was also effective without any obvious side-effects or toxicity. The potency of HUHS015, however, is not satisfying. We thought the reason is poor solubility of HUHS015 because insoluble material remained at the injection site after subcutaneous administration. To improve this inhibitor's solubility, we prepared various salts of HUHS015 and examined their solubility, which resulted in the selection of HUHS015 sodium salt ( 2: ) for further studies in vivo. Next, we compared the pharmacokinetics of 1: and 2: via several administration routes. We observed significant improvements in the pharmacokinetic parameters. For example, subcutaneous administration of 2: increased the area under the curve (AUC)0-24 by 8-fold compared to 1 and increased the suppressive effect on the proliferation of DU145 cells in a xenograft model.
2.Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs.
Nakao S1, Mabuchi M2, Shimizu T1, Itoh Y1, Takeuchi Y1, Ueda M1, Mizuno H2, Shigi N3, Ohshio I3, Jinguji K3, Ueda Y3, Yamamoto M4, Furukawa T4, Aoki S5, Tsujikawa K3, Tanaka A6. Bioorg Med Chem Lett. 2014 Feb 15;24(4):1071-4. doi: 10.1016/j.bmcl.2014.01.008. Epub 2014 Jan 11.
A series of 1-aryl-3,4-substituted-1H-pyrazol-5-ol derivatives was synthesized and evaluated as prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors to obtain a novel anti-prostate cancer drug. After modifying 1-(1H-benzimidazol-2-yl)-3,4-dimethyl-1H-pyrazol-5-ol (1), a hit compound found during random screening using a recombinant PCA-1/ALKBH3, 1-(1H-5-methylbenzimidazol-2-yl)-4-benzyl-3-methyl-1H-pyrazol-5-ol (35, HUHS015), was obtained as a potent PCA-1/ALKBH3 inhibitor both in vitro and in vivo. The bioavailability (BA) of 35 was 7.2% in rats after oral administration. As expected, continuously administering 35 significantly suppressed the growth of DU145 cells, which are human hormone-independent prostate cancer cells, in a mouse xenograft model without untoward effects.
3.Effect of loading rate on the apparent fracture toughness of acrylic bone cement.
Lewis G1. Biomed Mater Eng. 2002;12(2):149-55.
In this study, a determination is made of the effect of loading rate, v (0.1 mm min(-1) versus 1.0 mm min(-1) versus 10 mm min(-1)) on the value of the plane strain fracture toughness, K(Ic), of three commercial formulations of acrylic bone cement (Osteopal), CMW3, and Copal), that are characterized as "low-", "medium-", and "high-" viscosity brands, respectively). For all formulations, K(Ic) increases with increase in v. However, while this trend is statistically significant for CMW3 and Copal, this is not so for Osteopal. The CMW3 and Copal results are explained in terms of changes of the molecular relaxation transitions in the cement and the thermal state at the crack tip of the test specimen. Two implications of the findings are discussed. In the case of Osteopal, a recommendation for further study is made.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


AR12463
(CAS: 100557-04-8)

AR12456 is a trapidil derivative. It protects against serum hyperlipidemia in guinea pigs. It has a strong antilipidemic action in guinea pigs fed a cholesterol...

CAS 84573-16-0 Rocaglamide

Rocaglamide
(CAS: 84573-16-0)

Rocaglamide is the first cyclopenta[b]benzofuran derivative extracted from Aglaia elliptifolia in 1982 by King and colleagues. Its IC50 value is ~50 nM for the ...

CAS 1141777-14-1 Emixustat

Emixustat
(CAS: 1141777-14-1)

Emixustat, a novel visual cycle modulator, is a nonretinoid compound that directly inhibits RPE65, but does not bind to RAR/<br/>RXR retinoid receptors or antag...

CAS 10212-25-6 Cyclocytidine HCl

Cyclocytidine HCl
(CAS: 10212-25-6)

Cyclocytidine is the prodrug of cytarabine, which is a pyrimidine nucleoside analog that inhibits the DNA synthesis and used mainly in the treatment of leukemia...

CAS 2179-37-5 Benzcyclane

Benzcyclane
(CAS: 2179-37-5)

Benzcyclane, also called as Bencyclane or Benzcyclan, is a platelet aggregation inhibitor and used as a vasodilator effective.

CAS 6823-69-4 GW4869

GW4869
(CAS: 6823-69-4)

GW4869 is a cell-permeable, specific and non-competitive inhibitor of neutral sphingomyelinases (IC50 = 1 μM).

CAS 1025015-40-0 GK921

GK921
(CAS: 1025015-40-0)

GK921 is a transglutaminase 2 (TGase 2) inhibitor with average GI50 of 0.9 μM in cancer cell lines.

CAS 918633-87-1 Evofosfamide

Evofosfamide
(CAS: 918633-87-1)

Evofosfamide, also known as TH-302, is a hypoxia-activated prodrug consisting of a 2-nitroimidazole phosphoramidate conjugate with potential antineoplastic act...

BPH715
(CAS: 1059677-23-4)

BPH715 is a new generation of lipophilic bisphosphonates. It is potent in cell culture and effectively inhibited tumor cell growth and invasiveness. It is used ...

CAS 1465248-60-5 SPL-B

SPL-B
(CAS: 1465248-60-5)

SPL-B is an orally active inhibitor of transforming acidic coiled-coil protein (TACC3) exhibiting an inhibitory effect against the nucleation of centrosome micr...

CAS 938-73-8 2-Ethoxybenzamide

2-Ethoxybenzamide
(CAS: 938-73-8)

2-Ethoxybenzamide is a common analgesic and anti-inflammatory drug. It is used to reduce the fever, headaches, and other minor aches and pains. It is an ingredi...

CAS 129909-90-6 Amicarbazone

Amicarbazone
(CAS: 129909-90-6)

The phenotypic responses of sensitive plants exposed to amicarbazone include chlorosis, stunted growth, tissue necrosis, and death. Its efficacy as both a folia...

CAS 1246638-08-3 N-Desmethyl Ivabradine HCl

N-Desmethyl Ivabradine HCl
(CAS: 1246638-08-3)

The hydrochloride salt form of N-Desmethyl Ivabradine which is an derivative of Ivabradine generated through metabolism.

CAS 1649450-12-3 ML352

ML352
(CAS: 1649450-12-3)

ML352 is a potent and non-competitive inhibitor of the presynaptic choline transporter (CHT; Ki value 92 nM).

CAS 199666-03-0 Ro 61-8048

Ro 61-8048
(CAS: 199666-03-0)

Potent and competitive kynurenine 3-hydroxylase inhibitor (IC50 = 37 nM). Shows antidystonic, anticonvulsant and neuroprotective effects in vivo. Blood-brain ba...

Imiquimod hydrochloride
(CAS: 99011-78-6)

Imiquimod hydrochloride is an immune response modifier. It acts as a toll-like receptor 7 agonist. It is commonly used topically to treat warts on the skin of t...

CAS 500-38-9 Nordihydroguaiaretic acid

Nordihydroguaiaretic acid
(CAS: 500-38-9)

NDGA (Nordihydroguaiaretic acid), also known as masoprocol,  is a naturally occurring antioxidant dicatechol originally derived from the creosote bush Larrea di...

CAS 7631-95-0 Sodium Molybdate, anhydrous

Sodium Molybdate, anhydrous
(CAS: 7631-95-0)

Sodium molybdate is used as source of molybdate and it is often used in the form of Sodium molybdate dihydrate. It inactivated both the active and inactive form...

CAS 102791-47-9 Nanterinone

Nanterinone
(CAS: 102791-47-9)

Nanterinone is a novel positive inotropic and balanced-type vasodilating drug partially based on phosphodiesterase III inhibition. It exhibits acute hemodynamic...

AT-1459
(CAS: 294658-50-7)

AT-1459 is a novel, direct thrombin inhibitor with antithrombotic efficacy (Ki = 4.9 nM).

Chemical Structure

CAS 1453097-13-6 HUHS015

Quick Inquiry

Verification code

Featured Items